Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease

Margarita Giraldo, Francisco Lopera, Ashley L. Siniard, Jason J. Corneveaux, Isabelle Schrauwen, Julian Carvajal, Claudia Muñoz, Manuel Ramirez-Restrepo, Chris Gaiteri, Amanda J. Myers, Richard John Caselli, Kenneth S. Kosik, Eric M. Reiman, Matthew J. Huentelman

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increased risk of Alzheimer's disease. TREM2 mutations are the genetic basis for a condition characterized by polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) and an early-onset dementia syndrome. TREM2 is important in the phagocytosis of apoptotic neuronal cells by microglia in the brain. Loss of function might lead to an impaired clearance and to accumulation of necrotic debris and subsequent neurodegeneration. In this study, we investigated a consanguineous family segregating autosomal recessive behavioral variant FTLD from Antioquia, Colombia. Exome sequencing identified a nonsense mutation in TREM2 (p.Trp198X) segregating with disease. Next, using a cohort of clinically characterized and neuropathologically verified sporadic AD cases and controls, we report replication of the AD risk association at rs75932628 within TREM2 and demonstrate that TREM2 is significantly overexpressed in the brain tissue from AD cases. These data suggest that a mutational burden in TREM2 may serve as a risk factor for neurodegenerative disease in general, and that potentially this class of TREM2 variant carriers with dementia should be considered as having a molecularly distinct form of neurodegenerative disease.

Original languageEnglish (US)
JournalNeurobiology of Aging
Volume34
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Frontotemporal Lobar Degeneration
Myeloid Cells
Neurodegenerative Diseases
Dementia
Alzheimer Disease
Exome
Colombia
Nonsense Codon
Brain
Microglia
Phagocytosis
Mutation
Genes
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy

Keywords

  • Alzheimer's disease
  • FTLD
  • Neurodegeneration
  • TREM2

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. / Giraldo, Margarita; Lopera, Francisco; Siniard, Ashley L.; Corneveaux, Jason J.; Schrauwen, Isabelle; Carvajal, Julian; Muñoz, Claudia; Ramirez-Restrepo, Manuel; Gaiteri, Chris; Myers, Amanda J.; Caselli, Richard John; Kosik, Kenneth S.; Reiman, Eric M.; Huentelman, Matthew J.

In: Neurobiology of Aging, Vol. 34, No. 8, 08.2013.

Research output: Contribution to journalArticle

Giraldo, M, Lopera, F, Siniard, AL, Corneveaux, JJ, Schrauwen, I, Carvajal, J, Muñoz, C, Ramirez-Restrepo, M, Gaiteri, C, Myers, AJ, Caselli, RJ, Kosik, KS, Reiman, EM & Huentelman, MJ 2013, 'Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease', Neurobiology of Aging, vol. 34, no. 8. https://doi.org/10.1016/j.neurobiolaging.2013.02.016
Giraldo, Margarita ; Lopera, Francisco ; Siniard, Ashley L. ; Corneveaux, Jason J. ; Schrauwen, Isabelle ; Carvajal, Julian ; Muñoz, Claudia ; Ramirez-Restrepo, Manuel ; Gaiteri, Chris ; Myers, Amanda J. ; Caselli, Richard John ; Kosik, Kenneth S. ; Reiman, Eric M. ; Huentelman, Matthew J. / Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. In: Neurobiology of Aging. 2013 ; Vol. 34, No. 8.
@article{980259c61a81439995e5749d9e0a1cf7,
title = "Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease",
abstract = "Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increased risk of Alzheimer's disease. TREM2 mutations are the genetic basis for a condition characterized by polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) and an early-onset dementia syndrome. TREM2 is important in the phagocytosis of apoptotic neuronal cells by microglia in the brain. Loss of function might lead to an impaired clearance and to accumulation of necrotic debris and subsequent neurodegeneration. In this study, we investigated a consanguineous family segregating autosomal recessive behavioral variant FTLD from Antioquia, Colombia. Exome sequencing identified a nonsense mutation in TREM2 (p.Trp198X) segregating with disease. Next, using a cohort of clinically characterized and neuropathologically verified sporadic AD cases and controls, we report replication of the AD risk association at rs75932628 within TREM2 and demonstrate that TREM2 is significantly overexpressed in the brain tissue from AD cases. These data suggest that a mutational burden in TREM2 may serve as a risk factor for neurodegenerative disease in general, and that potentially this class of TREM2 variant carriers with dementia should be considered as having a molecularly distinct form of neurodegenerative disease.",
keywords = "Alzheimer's disease, FTLD, Neurodegeneration, TREM2",
author = "Margarita Giraldo and Francisco Lopera and Siniard, {Ashley L.} and Corneveaux, {Jason J.} and Isabelle Schrauwen and Julian Carvajal and Claudia Mu{\~n}oz and Manuel Ramirez-Restrepo and Chris Gaiteri and Myers, {Amanda J.} and Caselli, {Richard John} and Kosik, {Kenneth S.} and Reiman, {Eric M.} and Huentelman, {Matthew J.}",
year = "2013",
month = "8",
doi = "10.1016/j.neurobiolaging.2013.02.016",
language = "English (US)",
volume = "34",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease

AU - Giraldo, Margarita

AU - Lopera, Francisco

AU - Siniard, Ashley L.

AU - Corneveaux, Jason J.

AU - Schrauwen, Isabelle

AU - Carvajal, Julian

AU - Muñoz, Claudia

AU - Ramirez-Restrepo, Manuel

AU - Gaiteri, Chris

AU - Myers, Amanda J.

AU - Caselli, Richard John

AU - Kosik, Kenneth S.

AU - Reiman, Eric M.

AU - Huentelman, Matthew J.

PY - 2013/8

Y1 - 2013/8

N2 - Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increased risk of Alzheimer's disease. TREM2 mutations are the genetic basis for a condition characterized by polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) and an early-onset dementia syndrome. TREM2 is important in the phagocytosis of apoptotic neuronal cells by microglia in the brain. Loss of function might lead to an impaired clearance and to accumulation of necrotic debris and subsequent neurodegeneration. In this study, we investigated a consanguineous family segregating autosomal recessive behavioral variant FTLD from Antioquia, Colombia. Exome sequencing identified a nonsense mutation in TREM2 (p.Trp198X) segregating with disease. Next, using a cohort of clinically characterized and neuropathologically verified sporadic AD cases and controls, we report replication of the AD risk association at rs75932628 within TREM2 and demonstrate that TREM2 is significantly overexpressed in the brain tissue from AD cases. These data suggest that a mutational burden in TREM2 may serve as a risk factor for neurodegenerative disease in general, and that potentially this class of TREM2 variant carriers with dementia should be considered as having a molecularly distinct form of neurodegenerative disease.

AB - Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increased risk of Alzheimer's disease. TREM2 mutations are the genetic basis for a condition characterized by polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) and an early-onset dementia syndrome. TREM2 is important in the phagocytosis of apoptotic neuronal cells by microglia in the brain. Loss of function might lead to an impaired clearance and to accumulation of necrotic debris and subsequent neurodegeneration. In this study, we investigated a consanguineous family segregating autosomal recessive behavioral variant FTLD from Antioquia, Colombia. Exome sequencing identified a nonsense mutation in TREM2 (p.Trp198X) segregating with disease. Next, using a cohort of clinically characterized and neuropathologically verified sporadic AD cases and controls, we report replication of the AD risk association at rs75932628 within TREM2 and demonstrate that TREM2 is significantly overexpressed in the brain tissue from AD cases. These data suggest that a mutational burden in TREM2 may serve as a risk factor for neurodegenerative disease in general, and that potentially this class of TREM2 variant carriers with dementia should be considered as having a molecularly distinct form of neurodegenerative disease.

KW - Alzheimer's disease

KW - FTLD

KW - Neurodegeneration

KW - TREM2

UR - http://www.scopus.com/inward/record.url?scp=84877618309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877618309&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2013.02.016

DO - 10.1016/j.neurobiolaging.2013.02.016

M3 - Article

C2 - 23582655

AN - SCOPUS:84877618309

VL - 34

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -